Hans G B Oger

Title: Innovation in Lipid Metabolism: The Contributions of Hans G. Böger

Introduction: Hans G. Böger, a notable inventor located in Hofheim am Taunus, Germany, has made significant contributions to the field of pharmacology with a focus on lipid metabolism. His innovative work is encapsulated in a patent that addresses crucial health issues related to lipid disorders.

Latest Patents: Hans G. Böger holds a prominent patent concerning pyrimidine compounds, specifically categorized under the formula I, which possesses unique characteristics with various substituents (R.sup.1 to R.sup.6). This patent not only details the compounds themselves but also emphasizes their readily water-soluble salts and a process for their preparation. These compounds have been identified as beneficial in treating lipid metabolism disorders by stimulating the hepatic LDL receptor. Furthermore, compounds under the formula II and their respective salts are also discussed, showcasing a broad scope of application in medical treatments.

Career Highlights: Throughout his career, Hans has been associated with Hoechst Aktiengesellschaft, a German pharmaceutical and life sciences company known for its innovative contributions to health and medicine. This affiliation has allowed him to work on impactful projects focusing on metabolic disorders and their treatments.

Collaborations: Hans G. Böger has collaborated with esteemed colleagues such as Klaus-Dieter Kampe and Ernold Granzer. Together, they have contributed to the advancement of synthetic methods and the development of compounds aimed at improving health outcomes in patients suffering from lipid metabolism issues.

Conclusion: Hans G. Böger's innovative spirit and dedicated research have led to important advancements in the understanding and treatment of lipid metabolism disorders. His work continues to influence the pharmaceutical landscape, offering hope for effective treatments and showcasing the importance of collaboration in scientific breakthroughs.